Formulations of deacetylase inhibitors

Details for Australian Patent Application No. 2008204928 (hide)

Owner Novartis AG

Inventors Tong, Wei-Qin; Buranachokpaisan, Thitiwan; Jiang, Wen-Lei

Agent Davies Collison Cave

Pub. Number AU-B-2008204928

PCT Pub. Number WO2008/086330

Priority 60/884,237 10.01.07 US

Filing date 8 January 2008

Wipo publication date 17 July 2008

Acceptance publication date 31 March 2011

International Classifications

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 31/4045 (2006.01)

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/086330 Priority application(s): WO2008/086330

31 March 2011 Application Accepted

  Published as AU-B-2008204928

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008204949-System and method for dynamically partitioning context servers

2008204923-Method for determining the stability of organic methyleneamines in the presence of semicarbazide-sensitive amine oxidase